One patient had a mutation in ERBB4, and the expression of this gene appears to correlate with non‐metastatic pancreatic cancer and a more favorable outcome (Thybusch‐Bernhardt et al., 2001). The gene discussed is ERBB4; the disease is familial pancreatic carcinoma.